BOSTON SCIENTIFIC OFFERS STENT ASSURANCE PROGRAM

Boston Scientific recently introduced a new program providing participating U.S. medical centers a Taxus Express2 stent system at no additional charge if a patient requires re-intervention due to in-stent restenosis of a previously implanted Taxus Express2 stent. The program will run from Jan. 1 to Dec. 31, 2006.

To be eligible for participation in the program, a medical center must enroll in advance through their Boston Scientific sales representative. The offer applies if a patient with the stent returns to the medical center within 12 months of implantation because of restenosis.

"The Taxus Stent Assurance Program is our way of saying that we stand squarely and confidently behind our product," said Hank Kucheman, president of the company's interventional cardiology business.